Selection of effective concentrations of paclitaxel drugs for the treatment of anaplastic thyroid cancer
Authors:
Open Access
- 30 December 2025
- journal article
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 21 (8) , 807-811
Abstract
Background. Anaplastic thyroid cancer (ATС) is one of the most aggressive forms of human cancer and has an extremely poor prognosis. In most cases, the tumor is inoperable. ATС, even in the absence of metastases, is considered as a stage IV systemic disease at the time of diagnosis. The recommended therapy includes intervention with the aim of maximum possible resection of the tumor (cytoreductive surgery). Since the surgical method cannot be radical, adjuvant therapy is always necessary in the form of subsequent targeted therapy, radiotherapy, etc. An urgent task facing scientists is the development and implementation of new therapeutic approaches that could significantly improve the situation with the treatment of ATC. Among the drugs used for its treatment, taxanes were noted for their highest effectiveness. The use of taxanes is limited due to their high toxicity. Therefore, research is relevant that would make it possible to choose the minimum concentrations of drugs that are still effective. The purpose of the work was to determine the minimum effective concentrations of paclitaxel (Ptx) regarding the survival of several ATC lines with different sensitivity to this drug. Materials and methods. The work used anaplastic thyroid cancer cells: KTC-2, ARO, FRO. They were cultured in RPMI-1640 medium containing 5% bovine serum, penicillin/streptomycin (100 U/ml/100 μg/ml), in an atmosphere with 5% CO2 at 37 °C. To determine the viability of anaplastic cancer cells, a WST test was performed. Results. The concentration sufficient for effective destruction of ATC cells in culture is 10 nM. Further increase in the amount of the drug up to 10,000 nM no longer affects the number of dead cells. Conclusions. The studied anaplastic thyroid cancer lines are sensitive to Ptx, with varying degrees of sensitivity. Effective cytotoxic concentrations of Ptx start at 10 nM. Further increase in drug concentration does not lead to increased tumor cell death. For the death of the entire tumor cell population, incubation with Ptx must last more than 72 hours.Keywords
This publication has 18 references indexed in Scilit:
- Aneuploidy as a promoter and suppressor of malignant growthNature Reviews Cancer, 2021
- Preclinical and clinical combination therapies in the treatment of anaplastic thyroid cancerMedical Oncology, 2020
- A revisited concept. Tumors: Wounds that do not healCritical Reviews in Oncology/Hematology, 2018
- Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapiesNature Reviews Endocrinology, 2017
- Clinical Pharmacokinetics of Paclitaxel Monotherapy: An Updated Literature ReviewClinical Pharmacokinetics, 2017
- The Safety and Efficacy of Weekly Paclitaxel Administration for Anaplastic Thyroid Cancer Patients: A Nationwide Prospective StudyThyroid®, 2016
- Tumors: Wounds That Do Not Heal—ReduxCancer Immunology Research, 2015
- American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid CancerThyroid®, 2012
- A Phase I and Pharmacokinetic Study of Exisulind and Docetaxel in Patients with Advanced Solid TumorsClinical Cancer Research, 2004
- Analysis of docetaxel pharmacokinetics in humans with the inclusion of later sampling time-points afforded by the use of a sensitive tandem LCMS assayCancer Chemotherapy and Pharmacology, 2003